Home › Alpha-1 Antitrypsin Deficiency › Massachusetts › Boston
Alpha-1 Antitrypsin Deficiency clinical trials in Boston, MA
4 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
RecruitingPhase 1/2
- Clinical Study Center, Boston
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
RecruitingPhase 3
- Brigham and Womens Hospital, Boston
- Boston Medical Center, Boston
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
RecruitingPhase 1/2
- Clinical Study Center, Boston
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
RecruitingPhase 3
- Boston Medical Center, Boston
About Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency is an inherited condition that raises your risk for lung and liver disease. Learn about the symptoms and treatment.
More about Alpha-1 Antitrypsin Deficiency on MedlinePlus
Alpha-1 Antitrypsin Deficiency trials in other cities
- Gainesville, FL6 studies
- Charleston, SC6 studies
- Birmingham, AL5 studies
- New York City, NY4 studies
- Rochester, MN4 studies
- Cleveland, OH3 studies
- Phoenix, AZ3 studies
- Miami, FL3 studies
- Los Angeles, CA3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.